Inarigivir Uses, Dosage, Side Effects and more
Inarigivir is under investigation in clinical trial NCT03434353 (Study to Evaluate the Antiviral Activity of Inarigivir (GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)).
| Trade Name | Inarigivir |
| Generic | Inarigivir |
| Type | |
| Formula | C20H26N7O10PS |
| Weight | Average: 587.5 Monoisotopic: 587.119948237 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
